The power of 7,000 proteins is coming to HUPO 2022
Measure 7,000 proteins simultaneously from a 55-µL biological sample.
Gain deeper insights with proteomics
See us in person at HUPO 2022 from December 4-8 in Cancún, Mexico.
Experience the power of the SomaScan® Assay!
After two virtual editions, SomaLogic will join thousands of researchers and other attendees in person at HUPO 2022.
Interested in any of our events at HUPO 2022? Email us!
Visit us at booth 202, and join us at the following events:
Pre-Congress Workshop (PCW01):
Proteomic Studies Along the Lifespan
Sunday, December 4 – 8-10 am (EST)
Join us for an insightful discussion of how population proteomics can be used for discovery of human disease normal biology and pathophysiology across the lifespan, as well as for translation into clinical practice.
Speakers will discuss pre-analytic considerations, applications across populations — including identifying protein markers for health and disease, and how this can be translated into drug development and clinical assays. The workshop will conclude with a roundtable discussion led by speakers who will field questions on the use of large-scale proteomic assays in human cohorts.
Towia Libermann, PhD
Associate Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
Joseph Loureiro, PhD
Computational Biologist
Novartis Institutes for Biomedical Research
Claudia Langenberg
Director, Precision Healthcare University Research Institute
Professor of Medicine and Population Health
Queen Mary University of London
Professor, Berlin Institute of Health at Charité
Russell Bowler, MD, PhD
Director of Program in Precision Medicine
Director of COPD Clinic
Professor of Medicine
National Jewish Health
Accelerate your research,
or generate revenue as a service provider
Learn how you can run the SomaScan Assay within your own lab. As a SomaLogic certified site, you will not only receive the benefits of analyzing your samples in-house, but can also accelerate your workflow, automate your processes, and unlock revenue-generating capabilities. And our expert support team will assist you every step of the way. Learn more below. Or contact us to get started today.
Industry Supported Seminar (ISS04):
Toward Causality in Clinical Proteomics: Advantages and Challenges of Highly Specific Tools
Monday, December 5 — 13:15-14:15 (EST)
Grand Cancun 5 — Lunch will be provided.
Moderated by: Stephen Williams, MD, PhD, Chief Medical Officer, SomaLogic
Panelists include:
Russell Bowler, MD, PhD
Director of Program in Precision Medicine
Director of COPD Clinic
Professor of Medicine
National Jewish Health
Director, Precision Healthcare University Research Institute
Professor of Medicine and Population Health
Queen Mary University of London
Professor, Berlin Institute of Health at Charité
Associate Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
Staff Scientist Longitudinal Studies Section
Translational Gerontology Branch
National Institute on Aging
National Institutes of Health
Join us to learn about:
- High-plex proteomics methods used for translational applications in large clinical populations and complementarity with other approaches
- Statistical and machine learning approaches for developing protein models that reflect clinical phenotypes to predict outcomes and risk-stratify populations
HUPO poster sessions
Download our HUPO 2022 Poster Session Postcard for quick reference.
| Session Date and Time | Session Title | Theme | Presenter |
|---|---|---|---|
| Monday, Dec. 5 11:45am – 1:00pm |
PP01.91: Prognostic proteomic models for low event rates: a case study with myocardial infarction | Clinical Proteomics/ Precision Medicine |
Yolanda Hagar, PhD Associate Director, Bioinformatics |
| Monday, Dec. 5 11:45am – 1:00pm |
PP01.92: Efficient development of certified prognostic laboratory developed tests using proteomic data | Clinical Proteomics/ Precision Medicine |
Yolanda Hagar, PhD Associate Director, Bioinformatics |
| Wednesday, Dec. 7 11:45am – 1:00pm |
PP03.128: Models to predict pre-analytical variation | Plasma Proteomics | Nebojsa Janjic, PhD Chief Science Officer |
| Wednesday, Dec. 7 11:45am – 1:00pm |
PP03.131: Aptamer-based analysis of plasma proteome of growing tumours | Plasma Proteomics | Joe Gogain, PhD Director, Clinical R&D |
Come discover what advanced proteomics can mean for you
Visit us at booth #202, located in the main exhibit hall. Learn how to make groundbreaking discoveries possible in your own lab with the SomaScan Assay, speak with experts about your research needs, and pick up a free gift.
